Cardio Diagnostics Holdings, Inc.
CDIO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $422.7K in total; no superinvestor holds it.
Other share classesCDIOW
13F holders, Q3 2024
Institutional positions in Cardio Diagnostics Holdings, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- 0 vs. Q2 2024
- Shares held
- 1.68M
- +933.7K (+125.5%) vs. Q2 2024
- Total value
- $373.7K
- −$35.6K (−8.7%) vs. Q2 2024
- New holders
- 3
- 2 more added
- Sold out
- 3
- 1 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $422.7K |
| Q1 2026 | 16 | $538.1K |
| Q4 2025 | 16 | $351.0K |
| Q3 2025 | 14 | $462.2K |
| Q2 2025 | 16 | $332.0K |
| Q1 2025 | 23 | $836.3K |
| Q4 2024 | 23 | $2.36M |
| Q3 2024 | 15 | $373.7K |
| Q2 2024 | 16 | $996.1K |
| Q1 2024 | 14 | $2.30M |
| Q4 2023 | 14 | $4.12M |
| Q3 2023 | 15 | $152.4K |
| Q2 2023 | 10 | $445.3K |
| Q1 2023 | 11 | $1.31M |
| Q4 2022 | 12 | $248.8K |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Cardio Diagnostics Holdings, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,067,062 | $238.0K | 0.00% | +1,067,062 | New |
| Vanguard Group Inc | 232,139 | $51.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 184,409 | $41.1K | 0.00% | +9,855+5.6% | Added |
| Northern Trust Corp | 48,619 | $10.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 43,500 | $9.70K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 40,500 | $9.03K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 15,199 | $3.39K | 0.00% | 00.0% | Unchanged |
| Endowment Wealth Management, Inc. | 14,307 | $3.19K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 11,009 | $2.00K | 0.00% | +11,009 | New |
| Caldwell Sutter Capital, Inc. | 8,101 | $1.81K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,847 | $1.08K | 0.00% | −899−15.6% | Reduced |
| Wolverine Asset Management LLC | 3,777 | $842 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 3,150 | $693 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,000 | $223 | 0.00% | +1,000 | New |
| Bank of America Corp | 162 | $36 | 0.00% | +11+7.3% | Added |
| UBS Group AG | 0 | $0 | 0.00% | −90,906−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −57,434−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |